[Equine monocytic ehrlichiosis (EME), a review].
Serological surveys showed that equine monocytic ehrlichiosis (EME) occurs in the USA, Canada and Europe. The causative agent is Rickettsia Ehrlichia risticii, isolated for the first time in 1984. The clinical features of the disease are sluggishness, anorexia, colic and fever, possibly followed by watery diarrhoea. Complications of an infection with E. risticii are laminitis and abortion. Colitis of the ascending colon may be observed at autopsy. Following a positive serological diagnosis (IgM ELISA) of EME, treatment with oxytetracycline can be initiated. It is also important to restore the fluid and electrolyte balance by infusion. Prevention may be achieved by vaccination.
van der Kolk
J H
JH
Vakgroep Inwendige Ziekten en Voeding der Grote Huisdieren, Faculteit Diergeneeskunde, Utrecht.
de Groot
J
J
D000818:Animals; D003937:Diagnosis, Differential; D005440:Fluid Therapy / Q000662:veterinary; D006734:Horse Diseases / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D006736:Horses; D010118:Oxytetracycline / Q000627:therapeutic use; D012282:Rickettsia Infections / Q000175:diagnosis / Q000628:therapy / Q000662:veterinary*
D010118:Oxytetracycline
Equine monocytaire ehrlichiosis (EME), een overzicht.